Building Biological Artificial Superintelligence
Owkin is an AI biotech company pioneering biological artificial superintelligence to transform drug discovery and clinical trials. Using federated learning and agentic AI, Owkin processes multimodal patient data from hospitals and academic institutions to discover new biology and accelerate drug development. Its flagship product K Pro is an AI agent connecting research and clinical care.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2023
Jun 2022
Nov 2021
Nov 2021
Jun 2020
May 2020
Jul 2019
Jan 2019
Jan 2018
May 2017
Jan 2016
Create a free account to see which investors have funded this company.
Create Free Account
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
